149 related articles for article (PubMed ID: 35171422)
21. Silver Nanoparticles Exhibit the Dose-Dependent Anti-Proliferative Effect against Human Squamous Carcinoma Cells Attenuated in the Presence of Berberine.
Dziedzic A; Kubina R; Bułdak RJ; Skonieczna M; Cholewa K
Molecules; 2016 Mar; 21(3):365. PubMed ID: 26999092
[TBL] [Abstract][Full Text] [Related]
22. Berberine inhibits non-small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis.
Ni L; Li Z; Ren H; Kong L; Chen X; Xiong M; Zhang X; Ning B; Li J
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):134-144. PubMed ID: 34448246
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
[TBL] [Abstract][Full Text] [Related]
24. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
Parvathaneni V; Goyal M; Kulkarni NS; Shukla SK; Gupta V
Pharm Res; 2020 Jun; 37(7):123. PubMed ID: 32514688
[TBL] [Abstract][Full Text] [Related]
25. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
[TBL] [Abstract][Full Text] [Related]
26. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique.
Pund S; Borade G; Rasve G
Phytomedicine; 2014 Feb; 21(3):307-14. PubMed ID: 24176841
[TBL] [Abstract][Full Text] [Related]
27. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma.
Kabary DM; Helmy MW; Elkhodairy KA; Fang JY; Elzoghby AO
Colloids Surf B Biointerfaces; 2018 Sep; 169():183-194. PubMed ID: 29775813
[TBL] [Abstract][Full Text] [Related]
29. Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt/β-catenin signaling and EMT.
Dian L; Xu Z; Sun Y; Li J; Lu H; Zheng M; Wang J; Drobot L; Horak I
Phytochemistry; 2022 Aug; 200():113217. PubMed ID: 35504329
[TBL] [Abstract][Full Text] [Related]
30. Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment.
Achi IT; Sarbadhikary P; George BP; Abrahamse H
Cells; 2022 Oct; 11(21):. PubMed ID: 36359829
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
Wang Y; Yuan J; Yang L; Wang P; Wang X; Wu Y; Chen K; Ma R; Zhong Y; Guo X; Gong Y; Gui M; Jin Y
Adv Clin Exp Med; 2018 Jul; 27(7):899-905. PubMed ID: 29790698
[TBL] [Abstract][Full Text] [Related]
32. [Effect and mechanism of silibinin on the inhibition of ALK positive NSCLC cells by sensitizing crizotinib].
Lin CC; Lu CH; Pan YH; Jiao L; Chen HY; Li L; He Y
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):650-656. PubMed ID: 28926892
[No Abstract] [Full Text] [Related]
33. Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages.
Alnuqaydan AM; Almutary AG; Azam M; Manandhar B; De Rubis G; Madheswaran T; Paudel KR; Hansbro PM; Chellappan DK; Dua K
Nanomaterials (Basel); 2022 Dec; 12(23):. PubMed ID: 36500935
[TBL] [Abstract][Full Text] [Related]
34. p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.
Hou X; Gong R; Zhan J; Zhou T; Ma Y; Zhao Y; Zhang Y; Chen G; Zhang Z; Ma S; Chen X; Gao F; Hong S; Luo F; Fang W; Yang Y; Huang Y; Chen L; Yang H; Zhang L
BMC Cancer; 2018 Jun; 18(1):641. PubMed ID: 29879950
[TBL] [Abstract][Full Text] [Related]
35. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.
Wang L; Li H; Wang S; Liu R; Wu Z; Wang C; Wang Y; Chen M
AAPS PharmSciTech; 2014 Aug; 15(4):834-44. PubMed ID: 24696391
[TBL] [Abstract][Full Text] [Related]
37. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
[TBL] [Abstract][Full Text] [Related]
38. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
Liu H; Li Y; Zhang X; Shi M; Li D; Wang Y
Can Respir J; 2022; 2022():8509396. PubMed ID: 35465190
[TBL] [Abstract][Full Text] [Related]
40. 9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity.
Chang JM; Wu JY; Chen SH; Chao WY; Chuang HH; Kam KH; Zhao PW; Li YZ; Yen YP; Lee YR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
